Business
Voyageur and Altillion Forge Landmark Alliance to Establish North America's First Vertically Integrated Iodine Drug Supply Chain
(TheNewswire) Calgary, Alberta – TheNewswire - June 23, 2025 – ...
About this update from Voyageur Pharmaceuticals Ltd
[{"type":"text","content":"Voyageur and Altillion Forge Landmark Alliance to Establish North America's First Vertically Integrated Iodine Drug Supply Chain\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Calgary, Alberta –\n \n\n TheNewswire -\n \n\n June 23, 2025\n \n\n –\n \n\n Voyageur Pharmaceuticals Ltd.\n(TSXV:VM) (“Voyageur” or the “Company”),\n \n\n a Canadian public company developing cost-effective imaging contrast\nmedia, is pleased to announce the signing of a non-binding Memorandum\nof Understanding (MOU) with U.S. based\n \n\n Altillion Inc.\n \n\n , a\nleading technology innovator in mineral extraction. The collaboration\nmarks the launch of\n \n\n Phase\n1\n \n\n in Voyageur’s plan to develop North\nAmerica’s first fully integrated iodine-based drug manufacturing\nplatform, building on progress in its barium contrast media\nprogram.\n \n\n\n\n Securing Domestic Iodine – From\nBrine to Drug\n \n\n\n\n Under the MOU, Voyageur and Altillion will validate the\neconomics of Altillion’s\n \n\n proprietary\n \n\n iodine\nextraction technology,\n \n\n targeting recovery rates\nof 90% and purity exceeding 99% I₂ crystalline flake, a critical\npharmaceutical grade standard. Benchmark pricing for I\n \n\n 2\n \n\n flake currently sits at USD $70/kg\n($70,000/tonne) (source:\n \n\n\n Iofina\n \n\n\n ).\n \n\n\n\n A bench-scale test will be conducted as a foundation\nfor a broader feasibility study by an independent engineering firm.\nThe study will assess technical, regulatory, and economic parameters\nfor building:\n \n\n\n\n\n\n An iodine extraction facility on a saltwater disposal\nsite in Oklahoma.\n \n\n\n\n\n\n A pharmaceutical manufacturing campus in\nTexas.\n \n\n\n\n\n\n This infrastructure will serve as the foundation for\nVoyageur’s vertical integration strategy in Iodine-based\npharmaceuticals.\n \n\n\n\n\n\n A\nFour-Phase Plan to Build the U.S. Iodine Drug Supply Chain\n \n\n\n\n Voyageur’s integration strategy will roll out in four\nphases:\n \n\n\n\n\n\n Phase 1: Bench scale testing:\n \n\n Validate Altillion’s extraction process and\nfinalize a licensing agreement for pharmaceutical iodine\nproduction.\n \n\n\n\n\n\n Phase 2: Pilot Production 200\ntonne/year\n \n\n : Build an Active Pharmaceutical\nIngr...